Exploring the Efficacy and Safety of Trastuzumab in HER2-positive Breast Cancer

This chapter explores the effectiveness and safety of trastuzumab for HER2-positive breast cancer treatment, focusing on cardiomyopathy risk factors, LVEF monitoring, and drug interactions. It also addresses potential adverse effects and recent advancements in treatment options for HER2-amplified disease.